Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrizio Maggi

Showing results (41-50 of 361) with videos related to

Pageof 37
Sort By:
Reviews in Medical Virology|August 27, 2022
Monkeypox: An international epidemicDaniele Focosi, Federica Novazzi, Andreina Baj, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 2, 2020
What is the optimal usage of coronavirus disease 2019 convalescent plasma donations?Daniele Focosi, Marco Tuccori, Guido Antonelli, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 25, 2024
An update on the anti-spike monoclonal antibody pipeline for SARS-CoV-2Daniele Focosi, Massimo Franchini, Arturo Casadevall, et al.
Reviews in Medical Virology|December 22, 2020
Viral infection neutralization tests: A focus on severe acute respiratory syndrome-coronavirus-2 with implications for convalescent plasma therapyDaniele Focosi, Fabrizio Maggi, Paola Mazzetti, et al.
Antiviral Research|January 16, 2022
Very low levels of remdesivir resistance in SARS-COV-2 genomes after 18 months of massive usage during the COVID19 pandemic: A GISAID exploratory analysisDaniele Focosi, Fabrizio Maggi, Scott McConnell, et al.
Journal of Medical Virology|November 4, 2022
Discriminating endogenous vaccine-elicited anti-Spike antibody responses from exogenous anti-Spike monoclonal antibodies: The case of EvusheldDaniele Focosi, Fabrizio Maggi, Shmuel Shoham, et al.
Viruses|July 2, 2021
SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal AntibodiesDaniele Focosi, Marco Tuccori, Andreina Baj, et al.
The Journal of Infectious Diseases|April 2, 2014
Torque Teno virus viremia correlates with intensity of maintenance immunosuppression in adult orthotopic liver transplantDaniele Focosi, Lisa Macera, Mauro Pistello, et al.
Future Microbiology|February 15, 2022
Spike mutations in SARS-CoV-2 AY sublineages of the Delta variant of concern: implications for the future of the pandemicDaniele Focosi, Fabrizio Maggi, Scott McConnell, et al.
Transfusion Medicine (Oxford, England)|April 26, 2021
Kinetics of anti-SARS-COV2 spike protein IgG and IgA antibodies at 4°C: Implications for convalescent plasma stabilityDaniele Focosi, Giovanna Moscato, Mauro Pistello, et al.
Pageof 37

Showing results (41-50 of 361) with videos related to

Sort By:
Pageof 37
Reviews in Medical Virology|August 27, 2022
Monkeypox: An international epidemicDaniele Focosi, Federica Novazzi, Andreina Baj, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 2, 2020
What is the optimal usage of coronavirus disease 2019 convalescent plasma donations?Daniele Focosi, Marco Tuccori, Guido Antonelli, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 25, 2024
An update on the anti-spike monoclonal antibody pipeline for SARS-CoV-2Daniele Focosi, Massimo Franchini, Arturo Casadevall, et al.
Reviews in Medical Virology|December 22, 2020
Viral infection neutralization tests: A focus on severe acute respiratory syndrome-coronavirus-2 with implications for convalescent plasma therapyDaniele Focosi, Fabrizio Maggi, Paola Mazzetti, et al.
Antiviral Research|January 16, 2022
Very low levels of remdesivir resistance in SARS-COV-2 genomes after 18 months of massive usage during the COVID19 pandemic: A GISAID exploratory analysisDaniele Focosi, Fabrizio Maggi, Scott McConnell, et al.
Journal of Medical Virology|November 4, 2022
Discriminating endogenous vaccine-elicited anti-Spike antibody responses from exogenous anti-Spike monoclonal antibodies: The case of EvusheldDaniele Focosi, Fabrizio Maggi, Shmuel Shoham, et al.
Viruses|July 2, 2021
SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal AntibodiesDaniele Focosi, Marco Tuccori, Andreina Baj, et al.
The Journal of Infectious Diseases|April 2, 2014
Torque Teno virus viremia correlates with intensity of maintenance immunosuppression in adult orthotopic liver transplantDaniele Focosi, Lisa Macera, Mauro Pistello, et al.
Future Microbiology|February 15, 2022
Spike mutations in SARS-CoV-2 AY sublineages of the Delta variant of concern: implications for the future of the pandemicDaniele Focosi, Fabrizio Maggi, Scott McConnell, et al.
Transfusion Medicine (Oxford, England)|April 26, 2021
Kinetics of anti-SARS-COV2 spike protein IgG and IgA antibodies at 4°C: Implications for convalescent plasma stabilityDaniele Focosi, Giovanna Moscato, Mauro Pistello, et al.
Pageof 37